Phase II trial of AZD 1446 as an adjunctive treatment to donepezil in patients with mild to moderate Alzheimer's disease.

Trial Profile

Phase II trial of AZD 1446 as an adjunctive treatment to donepezil in patients with mild to moderate Alzheimer's disease.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 30 Jun 2013

At a glance

  • Drugs AZD 1446 (Primary) ; Donepezil
  • Indications Alzheimer's disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 30 Jun 2013 Status changed from planning to discontinued, according to an AstraZeneca pipeline.
    • 09 Jan 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top